A new symptom-free sexually transmitted disease (STD) has surpassed Neisseria gonorrhea in prevalence among young adults in the US. In Australia too it is becoming a big menace, researchers say .
The new infection is named Mycoplasma genitalium and was first identified in the 1980s. It can cause inflammation of the urethra (the urinary passage from the bladder), in men, and inflammation of the cervix and the lining of the uterus in women, possibly leading to infertility.
In the current study, researchers at the University of Washington, Seattle, tested 1714 women and 1218 men between the ages of 18 and 27 years participating in Wave III of the National Longitudinal Study of Adolescent Health.
Results of the study are published in the American Journal of Public Health.
The investigators found Mycoplasma genitalium infection in 1.0 percent of the participants.
In contrast, the prevalence of gonorrhea was 0.4 percent. The prevalence of chlamydia infection was 4.2 percent.
The prevalence of Mycoplasma genitalium infection was 11 times higher among individuals living with a sexual partner, seven times higher among blacks and four times higher among those who use condoms during sex.
None of the genitalium-positive individuals had any discharge.
"Many M. genitalium infections are asymptomatic, like chlamydial infections,'' principal investigator Dr. Lisa Manhart said.
"However, unlike chlamydia, it is probably too soon to recommend widespread screening for M. genitalium.''
There are no commercial tests to detect the organism, she explained.
Furthermore, she and her colleagues note in their report that it is not clear "whether M. genitalium-infected persons require or benefit from treatment - and if so, what antimicrobial therapy should be recommended.''
Page: 1 Related medicine news :1
. Australian Scientists Silence Cancer Gene2
. Australia earmarks $74 Million to Fight Bird Flu3
. Australian Government To Stockpile Anti-Bird Flu Drug Relenza4
. Obesity among The Poor in Australia.5
. Increase In Health Insurance Premium Likely In Australia6
. Australian Company Gets $10 million For Developing Skin Cancer Gel7
. Australian Health funds stand accused8
. Bird flu scare in Australia9
. Australia to Show Leniency towards U.S. Pharmaceutical Companies10
. Australia awaits US FDA reports on ADHD drugs11
. No booster vaccine For every fourth child in Australia